{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:31:48Z","timestamp":1754145108385,"version":"3.41.2"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,16]]},"DOI":"10.7759\/cureus.88066","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T12:20:56Z","timestamp":1752668456000},"source":"Crossref","is-referenced-by-count":0,"title":["Idiopathic Intracranial Hypertension Without Papilledema: A Case Emphasizing the Diagnostic Value of Optic Nerve Sheath Ultrasound"],"prefix":"10.7759","author":[{"given":"Asif Mahbub","family":"Swapnil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Samiul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latif","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalil Fatih Ali","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrul","family":"Nijam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00298-7","article-title":"Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions","volume":"15","author":"Markey KA","year":"2016","unstructured":"Markey KA, Mollan SP, Jensen RH, Sinclair AJ. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol. 2016, 15:78-91. 10.1016\/S1474-4422(15)00298-7","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00503","article-title":"Idiopathic intracranial hypertension without papilledema (IIHWOP) in chronic refractory headache","volume":"9","author":"Favoni V","year":"2018","unstructured":"Favoni V, Pierangeli G, Toni F, et al.. Idiopathic intracranial hypertension without papilledema (IIHWOP) in chronic refractory headache. Front Neurol. 2018, 9:503. 10.3389\/fneur.2018.00503","journal-title":"Front Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/life11060472","article-title":"Current perspectives on idiopathic intracranial hypertension without papilloedema","volume":"11","author":"Mollan SP","year":"2021","unstructured":"Mollan SP, Chong YJ, Grech O, Sinclair AJ, Wakerley BR. Current perspectives on idiopathic intracranial hypertension without papilloedema. Life (Basel). 2021, 11:472. 10.3390\/life11060472","journal-title":"Life (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/adc.87.3.223","article-title":"Idiopathic intracranial hypertension: is papilloedema inevitable?","volume":"87","author":"Wraige E","year":"2002","unstructured":"Wraige E, Chandler C, Pohl KR. Idiopathic intracranial hypertension: is papilloedema inevitable?. Arch Dis Child. 2002, 87:223-4. 10.1136\/adc.87.3.223","journal-title":"Arch Dis Child"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0000000000000205","article-title":"Asymmetric papilledema in idiopathic intracranial hypertension","volume":"35","author":"Bidot S","year":"2015","unstructured":"Bidot S, Bruce BB, Saindane AM, Newman NJ, Biousse V. Asymmetric papilledema in idiopathic intracranial hypertension. J Neuroophthalmol. 2015, 35:31-6. 10.1097\/WNO.0000000000000205","journal-title":"J Neuroophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-006-0095-y","article-title":"Idiopathic intracranial hypertension: the validity of cross-sectional neuroimaging signs","volume":"48","author":"Agid R","year":"2006","unstructured":"Agid R, Farb RI, Willinsky RA, Mikulis DJ, Tomlinson G. Idiopathic intracranial hypertension: the validity of cross-sectional neuroimaging signs. Neuroradiology. 2006, 48:521-7. 10.1007\/s00234-006-0095-y","journal-title":"Neuroradiology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2019.04.023","article-title":"Systematic review and meta-analysis of MRI signs for diagnosis of idiopathic intracranial hypertension","volume":"116","author":"Kwee RM","year":"2019","unstructured":"Kwee RM, Kwee TC. Systematic review and meta-analysis of MRI signs for diagnosis of idiopathic intracranial hypertension. Eur J Radiol. 2019, 116:106-15. 10.1016\/j.ejrad.2019.04.023","journal-title":"Eur J Radiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a55f17","article-title":"Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children","volume":"81","author":"Friedman DI","year":"2013","unstructured":"Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013, 81:1159-65. 10.1212\/WNL.0b013e3182a55f17","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000066683.34093.e2","article-title":"Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis","volume":"60","author":"Farb RI","year":"2003","unstructured":"Farb RI, Vanek I, Scott JN, Mikulis DJ, Willinsky RA, Tomlinson G, terBrugge KG. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology. 2003, 60:1418-24. 10.1212\/01.wnl.0000066683.34093.e2","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-008-1149-x","article-title":"Non-invasive assessment of intracranial pressure using ocular sonography in neurocritical care patients","volume":"34","author":"Geeraerts T","year":"2008","unstructured":"Geeraerts T, Merceron S, Benhamou D, Vigu\u00e9 B, Duranteau J. Non-invasive assessment of intracranial pressure using ocular sonography in neurocritical care patients. Intensive Care Med. 2008, 34:2062-7. 10.1007\/s00134-008-1149-x","journal-title":"Intensive Care Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2007.00031.x","article-title":"Correlation of optic nerve sheath diameter with direct measurement of intracranial pressure","volume":"15","author":"Kimberly HH","year":"2008","unstructured":"Kimberly HH, Shah S, Marill K, Noble V. Correlation of optic nerve sheath diameter with direct measurement of intracranial pressure. Acad Emerg Med. 2008, 15:201-4. 10.1111\/j.1553-2712.2007.00031.x","journal-title":"Acad Emerg Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-011-2224-2","article-title":"Ultrasonography of optic nerve sheath diameter for detection of raised intracranial pressure: a systematic review and meta-analysis","volume":"37","author":"Dubourg J","year":"2011","unstructured":"Dubourg J, Javouhey E, Geeraerts T, Messerer M, Kassai B. Ultrasonography of optic nerve sheath diameter for detection of raised intracranial pressure: a systematic review and meta-analysis. Intensive Care Med. 2011, 37:1059-68. 10.1007\/s00134-011-2224-2","journal-title":"Intensive Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.0650","article-title":"Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial","volume":"78","author":"Mollan SP","year":"2021","unstructured":"Mollan SP, Mitchell JL, Ottridge RS, et al.. Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial. JAMA Neurol. 2021, 78:678-86. 10.1001\/jamaneurol.2021.0650","journal-title":"JAMA Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3312","article-title":"Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial","volume":"311","author":"Wall M","year":"2014","unstructured":"Wall M, McDermott MP, Kieburtz KD, et al.. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014, 311:1641-51. 10.1001\/jama.2014.3312","journal-title":"JAMA"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/377953-idiopathic-intracranial-hypertension-without-papilledema-a-case-emphasizing-the-diagnostic-value-of-optic-nerve-sheath-ultrasound","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T12:20:57Z","timestamp":1752668457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/377953-idiopathic-intracranial-hypertension-without-papilledema-a-case-emphasizing-the-diagnostic-value-of-optic-nerve-sheath-ultrasound"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.88066","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,16]]}}}